Skip to main content
Equibles
ATOS logo

ATOS · Atossa Therapeutics, Inc. · Webcasts, Transcripts & Audio

Track ATOS — free

Use ATOS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ATOS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.47 +0.13 (+5.56%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 7, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt as to the Company's ability to continue as a going concern. The accompanying Condensed Consolidated Financial Statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities should the Company be unable to continue as a going concern.”
View the 10-Q filed Aug 7, 2026
Market Cap
$20.06M
Shares
9.98M
Volume · Oct 5 48.34K Avg daily vol (3M) 74.51K

Atossa Therapeutics, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Atossa Therapeutics, Inc. (ATOS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Key facts CIK 1488039 CUSIP 04962H704 13F (30d) 1 filings 1 filers Visit website Investor relations